North America Liquid Biopsy Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Liquid Biopsy Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Liquid Biopsy Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Liquid Biopsy Market Regional Analysis

6.2 North America Liquid Biopsy Market Revenue 2016-2027 (US$ Million)

6.3 North America Liquid Biopsy Market Forecast Analysis

7. North America Liquid Biopsy Market Analysis – by Product & Services

7.1 Equipment

7.1.1 Overview
7.1.2 Equipment: North America Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.2 Reagents & Kits and Services

7.2.1 Overview
7.2.2 Reagents & Kits and Services: North America Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. North America Liquid Biopsy Market Analysis – by Sample

8.1 Blood Based

8.1.1 Overview
8.1.2 Blood Based: North America Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.2 Urine Based and Other samples

8.2.1 Overview
8.2.2 Urine Based and Other samples: North America Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. North America Liquid Biopsy Market Analysis – by Circulating Biomarker

9.1 Circulating Tumor Cells

9.1.1 Overview
9.1.2 Circulating Tumor Cells: North America Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.2 Exosomes and Free Nucleic Acid

9.2.1 Overview
9.2.2 Exosomes and Free Nucleic Acid: North America Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. North America Liquid Biopsy Market Analysis – by Application

10.1 Noninvasive Prenatal Testing

10.1.1 Overview
10.1.2 Noninvasive Prenatal Testing: North America Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

10.2 Oncology

10.2.1 Overview
10.2.2 Oncology: North America Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

10.3 Transplant Diagnostics and Other Applications

10.3.1 Overview
10.3.2 Transplant Diagnostics and Other Applications: North America Liquid Biopsy Market – Revenue and Forecast, 2016-2027 (US$ Million)

11. North America Liquid Biopsy Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America Liquid Biopsy Market Breakdown, by Key Country, 2019 and 2027 (%)
11.2.1.1 North America Liquid Biopsy Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.1.1 US: North America Liquid Biopsy Market Breakdown, by Product & Services
11.2.1.1.2 US: North America Liquid Biopsy Market Breakdown, by Sample
11.2.1.1.3 US: North America Liquid Biopsy Market Breakdown, by Circulating Biomarker
11.2.1.1.4 US: North America Liquid Biopsy Market Breakdown, by Application

11.2.1.2 Canada: North America Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.2.1 Canada: North America Liquid Biopsy Market Breakdown, by Product & Services
11.2.1.2.2 Canada: North America Liquid Biopsy Market Breakdown, by Sample
11.2.1.2.3 Canada: North America Liquid Biopsy Market Breakdown, by Circulating Biomarker
11.2.1.2.4 Canada: North America Liquid Biopsy Market Breakdown, by Application

11.2.1.3 Mexico : North America Liquid Biopsy Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.3.1 Mexico : North America Liquid Biopsy Market Breakdown, by Product & Services
11.2.1.3.2 Mexico : North America Liquid Biopsy Market Breakdown, by Sample
11.2.1.3.3 Mexico : North America Liquid Biopsy Market Breakdown, by Circulating Biomarker
11.2.1.3.4 Mexico : North America Liquid Biopsy Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Thermo Fisher Scientific Inc.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Bio-Rad Laboratories Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Exact Sciences Corporation

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Biocept, Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Inivata Ltd

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America Liquid Biopsy Market